ConductScience.org, home

Paper2139486

[Animal experiment studies of the toxicity of fluorodeoxyuridine (FUDR) and 5-fluorouracil (FU) within the scope of regional liver infusion chemotherapy].

Schlag P and 4 others. Langenbecks Arch Chir, 1990. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. [Animal experiment studies of the toxicity of fluorodeoxyuridine (FUDR) and 5-fluorouracil (FU) within the scope of regional liver infusion chemotherapy]. Papers, record 2139486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2139486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Animal experiment studies of the toxicity of fluorodeoxyuridine (FUDR) and 5-fluorouracil (FU) within the scope of regional liver infusion chemotherapy].
PubMed
Journal
Langenbecks Arch Chir
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2019-08-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schlag PP
2Yi JJ
3Friedl PP
4Hull WW
5Berger MM

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chemical and Drug Induced Liver InjuryMajor topic
FloxuridineMajor topic
FluorouracilMajor topic
Infusions, Intra-ArterialMajor topic
Animals
Bile
Female
Inactivation, Metabolic
Liver
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13155548Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.J Clin Oncol1985https://conductscience.org/library/papers/3155548PubMed
22877375[Regional chemotherapy in liver metastases and prognosis].Lebensversicher Med1986https://conductscience.org/library/papers/2877375PubMed
32939001[Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine].Gastroenterol Clin Biol1986https://conductscience.org/library/papers/2939001PubMed
43158217The implanted pump in metastatic colorectal cancer of the liver. Risk versus benefit.Am J Surg1985https://conductscience.org/library/papers/3158217PubMed
52937274Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation.AJR Am J Roentgenol1986https://conductscience.org/library/papers/2937274PubMed
62935243Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries.Cancer1986https://conductscience.org/library/papers/2935243PubMed
77398191Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes.Clin Pharmacol Ther1980https://conductscience.org/library/papers/7398191PubMed
82935242Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.Cancer1986https://conductscience.org/library/papers/2935242PubMed
93758367Regional arterial chemotherapy of liver tumours. I. Performance comparison between a totally implantable pump and a conventional access system.Eur J Surg Oncol1986https://conductscience.org/library/papers/3758367PubMed
102931170A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine.Cancer1985https://conductscience.org/library/papers/2931170PubMed
11384574
Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study.
Surgery1979https://conductscience.org/library/papers/384574PubMed
123818776Feasible model for locoregional and systemic longterm administration of drugs and concomitant blood sampling in Sprague-Dawley rats.J Cancer Res Clin Oncol1987https://conductscience.org/library/papers/3818776PubMed
132936747Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/2936747PubMed
143160313Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.Ann Surg1985https://conductscience.org/library/papers/3160313PubMed
156155210Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses.Cancer Treat Rep1980https://conductscience.org/library/papers/6155210PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2139486

GET https://conductscience.org/api/papers/v1/2139486/authors